Related references
Note: Only part of the references are listed.The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Up-regulation of PIK3CA promotes metastasis in gastric carcinoma
Ji-Fang Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis
Ganapati H. Mahabeleshwar et al.
CIRCULATION RESEARCH (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Exploring the specificity of the PI3K family inhibitor LY294002
Severine I. Gharbi et al.
BIOCHEMICAL JOURNAL (2007)
Integrin-regulated FAK-Src signaling in normal and cancer cells
Satyajit K. Mitra et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
The α6β4 integrin maintains the survival of human breast carcinoma cells in vivo
EA Lipscomb et al.
CANCER RESEARCH (2005)
Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers
P Michl et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2005)
The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt
GJ Chiang et al.
BJU INTERNATIONAL (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Structural basis for vinculin activation at sites of cell adhesion
C Bakolitsa et al.
NATURE (2004)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma
O Kahana et al.
ONCOGENE (2002)
Focal adhesions require catalytic activity of Src family kinases to mediate integrin-matrix adhesion
LM Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
